GREENWICH, Conn., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Associated Capital Group, Inc. (“AC” or the “Company”) (OTCQX: ACGP), announced today a preliminary range for its third quarter book value of $44.15 to $44.35 per share. This compares to $43.30 per share at June 30, 2025 and $42.14 per share at December 31, 2024. AC will be issuing further details on its financial results in November. About Associated Capital Group, Inc.Associated Capital Group, Inc. (OTCQX: ACGP), based in Greenwich, Connecticut, is a div ...

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Kinross Gold Corporation (TSX: K; NYSE: KGC) will release its financial statements and operating results for the third quarter of 2025 on Tuesday, November 4, 2025, after market close. On Wednesday, November 5, 2025, at 8:00 a.m. ET Kinross will hold a conference call and audio webcast to discuss the results, followed by a question-and-answer session. The call-in numbers are as follows: Canada & US toll-free – 1 (888) 596-4144; Passcode: 9425112Outside of Canada & ...

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) will release its third quarter 2025 operating and financial results after the market closes on Tuesday October 28, 2025. The Company will host a conference call and webcast to discuss the results on Wednesday October 29, 2025, at 9:00 a.m. Eastern Time. Details for the conference call and webcast are included below. Webcast Participants can access the webcast at the following webcast link.An ar ...

SASKATOON, Saskatchewan, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has completed the acquisitions of three community pharmacy businesses, two located in Western Canada and one located in Eastern Canada (collectively, the “Acquisitions”). Western Canada Acquisitions PharmaCorp has closed its previously announced acquisitions of two PharmaChoice Canada bannered pharmacies located in Western Canada, one of which includes ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Vancouver, BC, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Amaya Big Sky Capital Corp. (“Amaya” or the “Company”) (TSX-V: AMYA.P), a capital pool company pursuant to Policy 2.4 of the TSX Venture Exchange (the “TSX-V”), announces that, further to its news releases dated September 19, 2024 and December 17, 2024, it has amended several of the terms of its business combination agreement dated December 13, 2024 (the “Original Bu ...

JACKSONVILLE, Fla., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the “Company”) announced that the Company will host an investor conference call at 5:00 p.m. EST on Tuesday, November 11, 2025, to discuss its operating and financial results for the three months ended September 30, 2025. A press release disclosing those results will be issued at approximately 4:00 p.m. EST on that day. Investors are invited to join the conference call by registering through this link: https ...

收购要约核心条款 - XOMA Royalty Corporation宣布延长对LAVA Therapeutics N V所有已发行普通股的收购要约，收购对价包括现金及不可转让的或有价值权利[1] - 每份或有价值权利代表股东有权获得LAVA两项合作资产相关净收益的75%，以及LAVA未合作项目任何对外授权或出售所得净收益的75%[1] 要约时间表更新 - 收购要约原定于2025年10月3日美国东部时间晚上11:59过后一分钟到期，现延长至2025年10月17日美国东部时间晚上11:59过后一分钟[2] - 本次收购预计将于2025年第四季度完成，具体取决于惯例交割条件[2] - LAVA计划在2025年11月初之前召开股东大会审议相关交易事项[4] 要约条件与后续安排 - 要约交割需满足特定条件，包括至少80%（或在某些情况下75%）的LAVA已发行流通股被要约收购，以及股东大会通过特定决议和交割时最低现金余额等[4] - 在后续要约期内，LAVA将进行公司重组，旨在使XOMA Royalty收购LAVA继承公司100%的股份，其余所有股东将获得与要约收购中相同的现金和或有价值权利对价[4] - 此前已投标其股份的LAVA股东无需因要约延期而重新投标或采取任何其他行动，LAVA股东已签署支持协议，承诺在到期日前投标其股份并支持该要约[3] 公司业务概况 - XOMA Royalty是一家生物技术特许权聚合商，通过收购已授权给制药或生物技术公司的临床前及商业化治疗候选药物的潜在未来收益，为生物技术公司提供非稀释性、无追索权的资金[5] - LAVA Therapeutics N V是一家生物制药公司，利用其专有的Gammabody®平台开发了几种临床阶段的双特异性γδ T细胞衔接器，包括与强生公司合作的靶向CD33的JNJ-89853413，以及与辉瑞公司合作的靶向EGFR的PF-08046052[6]

Can humans really live to 150? In this video, Prof. Dato’ Sri Dr. Mike Chan of European Wellness Biomedical Group breaks down why organ transplants alone aren’t the answer and how cellular regeneration, stem cells, and mitochondrial peptides could hold the real key to extending healthspan and longevity. Learn more at https://european-wellness.eu/ From hot-mic whispers of World Leaders to groundbreaking science, Prof. Mike Chan reveals why cellular regeneration — not organ swaps, holds the key to ext ...

All amounts are in United States dollars, unless otherwise stated. TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) plans to release its third quarter 2025 financial results after market close on Wednesday October 29, 2025. Senior management will host a conference call on Thursday, October 30, 2025 at 10:00 am ET to discuss the results. Participants may join the conference call via webcast or through the following dial-in numbers: Toronto and Intern ...

Lantana, Fla., Oct. 02, 2025 (GLOBE NEWSWIRE) -- JFB Construction Holdings (Nasdaq: JFB) (the “Company”), a real estate development and construction company focused on hospitality, commercial, industrial, and residential property development, today announced that it has closed on a securities purchase agreement with American Ventures LLC, Series XIV JFB as the sole investor for a private investment in public equity (“PIPE”) financing that has resulted in gross proceeds to the Company of approximately $43,89 ...